After concluding the findings of a large scale trail that consumed almost a year, researchers have claimed that a newly developed malaria vaccine has competence to save a huge child population, globally. During the trail, scientist supplied the drug injection to more than 15,000 infants, aged 18 months or less, and observed that subjects who received the injection reported 50% less chances for developing malaria as compared to rest population of same age group.

Renowned pharmaceutical company, GlaxoSmithKline has credited to develop the vaccine and claimed to acknowledge extraordinary outcome.

Even in contemporary world, malaria is a major health problem, especially in low income and poor developing countries. As per the reports, it affects more than 225 million people every year, along with 800,000 malaria-related deaths.

Regions with hot climatic conditions, including a number of African countries, suffer a lot because of malaria as mosquitoes serve as an excellent carrier of the disease. However, a report by the World Health Organization has reflected a little bit progress and notified a 20% decline in the number of malaria deaths, during the past decade.

On the other hand, Mr. Bill Gates had tagged the innovation as a "huge milestone" and anticipated that the vaccination will be available for use, most probably by 2015, if the research on next level has also reflected positive results. Mr. Bill Gates has generously offered financial support to fund the study.

The healthcare community was surprised when Mr. Gates, along with his wife Melinda, notified malaria removal as their top most goals, around four years back. Sources have confirmed that up till now the Bill and Melinda Gates Foundation have contributed enough with a donation of $1.75 billion to eradicate the malaria.

During an interview, Mr. Gates has claimed that second level results will be deciding whether to develop the vaccine or not.